S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis
Open Access
- 18 March 2022
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-15
Abstract
Background. S100 Calcium Binding Protein A8 (S100A8) is beneficial for cancer immunotherapy. However, the processes underlying its therapeutic potential have not been completely studied. Methods. The Cancer Genome Atlas provides raw data on 33 different cancer types. GEO made available GSE67501, GSE78220, and IMvigor210. We investigated S100A8s genetic changes, expression patterns, and survival studies. The linkages between S100A8 and TME, as well as its association with immunological processes/elements and the major histocompatibility complex, were explored to effectively understand the role of S100A8 in cancer immunotherapy. Three distinct immunotherapeutic cohorts were employed to examine the relationship between S100A8 and immunotherapeutic response. Results. S100A8 expression was high in tumor tissue. The overexpression of S100A8 is associated with poor clinical outcome in patients with overall survival. S100A8 is associated with immune cell infiltration, immunological modulators, and immunotherapeutic indicators. S100A8 overexpression is connected to immune-related pathways. However, no statistically significant connection between S100A8 and immunotherapeutic response was identified. Conclusions. S100A8 may be a reliable biomarker for tumor prognosis and a viable prospective therapeutic target for human cancer immunotherapy (e.g., GBM, KIRC, LGG, and LIHC).Keywords
Funding Information
- Kaiyuan (2014Y238, 2017FF116(-028))
- Yunnan Provincial Department of Education (2014Y238, 2017FF116(-028))
- Joint Special Project of Yunnan Provincial Department of Science and Technology-Yunnan University of Traditional Chinese Medicine on Applied Basic Research (2014Y238, 2017FF116(-028))
- State Administration of Traditional Chinese Medicine of the People's Republic of China (2014Y238, 2017FF116(-028))
- Second Round of Construction Project of The National Traditional Chinese Medicine School Heritage Studio (2014Y238, 2017FF116(-028))
- Health and Health Commission of Yunnan Province 2020 High-level TCM Reserve Talents Incubation Project (2014Y238, 2017FF116(-028))
This publication has 43 references indexed in Scilit:
- A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinomaCancer Letters, 2015
- Molecular Interaction of a Kinase Inhibitor Midostaurin with Anticancer Drug Targets, S100A8 and EGFR: Transcriptional Profiling and Molecular Docking Study for Kidney Cancer TherapeuticsPLOS ONE, 2015
- S100 proteins in cancerNature Reviews Cancer, 2015
- S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritisThe Korean Journal of Internal Medicine, 2014
- Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkersClinical Immunology, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Dynamic Mobility of Immunological Cells Expressing S100A8 and S100A9 in vivo: A Variety of Functional Roles of the two Proteins as Regulators in Acute Inflammatory ReactionInflammation, 2011
- Damage-Associated Molecular Pattern S100A9 Increases Bactericidal Activity of Human Neutrophils by Enhancing PhagocytosisThe Journal of Immunology, 2011
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14)Biological Chemistry, 2005